A detailed history of Fmr LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 7,777,600 shares of JANX stock, worth $423 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,777,600
Previous 7,749,009 0.37%
Holding current value
$423 Million
Previous $292 Million 11.67%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$35.12 - $64.78 $1 Million - $1.85 Million
28,591 Added 0.37%
7,777,600 $326 Million
Q1 2024

May 13, 2024

BUY
$7.93 - $49.75 $24.4 Million - $153 Million
3,077,796 Added 65.89%
7,749,009 $292 Million
Q4 2023

Feb 13, 2024

SELL
$5.85 - $11.7 $9.83 Million - $19.7 Million
-1,680,109 Reduced 26.45%
4,671,213 $50.1 Million
Q3 2023

Nov 13, 2023

BUY
$9.56 - $14.0 $12.3 Million - $18 Million
1,288,526 Added 25.45%
6,351,322 $64 Million
Q2 2023

Aug 11, 2023

SELL
$11.08 - $15.92 $862,555 - $1.24 Million
-77,848 Reduced 1.51%
5,062,796 $60.1 Million
Q1 2023

May 11, 2023

SELL
$11.25 - $22.21 $5.23 Million - $10.3 Million
-465,216 Reduced 8.3%
5,140,644 $62.2 Million
Q4 2022

Feb 13, 2023

SELL
$11.1 - $18.26 $7.12 Million - $11.7 Million
-641,532 Reduced 10.27%
5,605,860 $73.8 Million
Q3 2022

Nov 10, 2022

BUY
$10.82 - $16.84 $4.56 Million - $7.1 Million
421,688 Added 7.24%
6,247,392 $84.6 Million
Q2 2022

Aug 12, 2022

BUY
$9.52 - $15.65 $1.42 Million - $2.33 Million
148,778 Added 2.62%
5,825,704 $71.1 Million
Q1 2022

May 13, 2022

BUY
$13.24 - $20.24 $9.08 Million - $13.9 Million
685,524 Added 13.73%
5,676,926 $81.4 Million
Q4 2021

Feb 14, 2022

BUY
$15.44 - $27.32 $21.2 Million - $37.6 Million
1,375,971 Added 38.06%
4,991,402 $98.5 Million
Q3 2021

Nov 15, 2021

BUY
$20.7 - $34.69 $36.7 Million - $61.5 Million
1,771,867 Added 96.11%
3,615,431 $78.2 Million
Q2 2021

Aug 13, 2021

BUY
$18.58 - $25.37 $34.3 Million - $46.8 Million
1,843,564 New
1,843,564 $46 Million

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.27B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.